Sutimlimab shows promise for hard-to-treat, rare blood disorder

In a first-in-human clinical trial, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare chronic blood disorder for which there are currently no approved treatments.

Leave a Reply

Your email address will not be published.